LD 143 establishes a dedicated fund within Maine's Department of Health and Human Services to maintain statewide access to family planning services. The bill allocates $6.18 million annually from the General Fund to be distributed as a single grant to a qualified provider selected through a competitive request for proposals. This provider will manage and oversee the delivery of family planning services across the state, including coordination with subrecipients. The fund is designed to ensure ongoing, non-lapsing funding for these services without replacing existing funding sources.
LD 1937 requires hospitals and certain hospital-affiliated outpatient providers (like those offering imaging, lab services, cardiac diagnostics, or expensive equipment-based care) to establish and maintain financial assistance programs for eligible patients. These programs must provide charity care consistent with existing rules, based on family income thresholds defined in the bill. Providers who deny access without justification face civil fines up to $10,000 per violation, enforced by the Attorney General or affected patients through court action. The bill repeals an older section (1716) and creates a new section (1716-A) to define charity care requirements and eligibility. It directly affects Maine hospitals and specific outpatient service providers meeting the bill's criteria.
LD 613 amends Maine's Death with Dignity Act to allow attending physicians to waive any portion or all of the waiting periods required for qualified patients to access end-of-life medication, based on the physician's medical assessment of the patient's condition. Physicians must document the waiver, including the specific portion waived and the medical reasoning that it serves the patient's best interests. This change directly affects patients eligible under Maine's Death with Dignity Act and their attending physicians. The amendment aims to improve timely access for patients facing urgent health circumstances without requiring the full waiting period.
LD 532 expands Maine's assault law to specifically protect all health care workers in hospital emergency rooms. The bill defines assault on these workers as a Class C crime, covering anyone employed or contracted by a state-licensed health care entity (including hospitals and clinics) while performing their job in the emergency room. This change directly affects health care workers in Maine's emergency departments by strengthening legal consequences for assaults against them. The key provision amends existing statute §752-F to broaden the definition beyond previous limitations, ensuring all licensed health care workers in emergency settings receive the same legal protection.
LD 380 amends Maine's Address Confidentiality Program to include gender-affirming health care practitioners as eligible participants, expanding the program beyond its prior focus on reproductive health care. This allows practitioners to use a designated address for mail and legal purposes, keeping their personal address confidential to enhance safety. The bill repeals prior provisions that had limited eligibility to reproductive health care practitioners and updates the program to cover both reproductive and gender-affirming services. The change is administrative and does not regulate the provision of health care services.
This bill amends Maine's paid family and medical leave laws to clarify employee leave options and strengthen program administration. It specifies that employees may take leave in hourly increments only if agreed upon with their employer, and creates a dedicated Bureau of Paid Family and Medical Leave within the Department of Labor to manage the program. The bill adds enforcement tools for unpaid employer payments, including civil lawsuits and property levies, and holds successor businesses liable for unpaid premiums from acquired employers. It also establishes fines for employers whose private leave plans lapse during approved substitutions, with collected fines directed to the state fund. These changes primarily affect Maine employers participating in the paid leave program and employees seeking leave benefits.
LD 1154 requires healthcare providers to inform women seeking an abortion for a fetus diagnosed with a lethal fetal anomaly (a condition likely to cause the baby's death within three months after birth) about perinatal hospice services as part of the informed consent process. Providers must discuss these services in person at least 24 hours before the procedure and provide a written list of available perinatal hospice providers, which the state will maintain. If the woman declines hospice services and chooses to proceed with the abortion, she must sign a written certification confirming her decision. This requirement does not apply in cases of medical emergencies or for abortions related to ectopic pregnancy or spontaneous miscarriage.
LD 1007 requires healthcare professionals in Maine to provide specific information during informed consent for drug-induced abortions. It mandates that providers inform patients about the potential for reversal if they change their mind (noting time sensitivity), and that initial studies suggest no increased maternal mortality or birth defect risks from reversal. Providers must also give patients a written statement with a website and helpline number (to be updated annually by the Department of Health) for information on abortion pill reversal services. This bill directly affects women seeking drug-induced abortions and their healthcare providers in Maine.
LD 886 regulates medication abortions in Maine by requiring in-person consultations and prescriptions from licensed health care professionals. It prohibits purchasing or obtaining medication abortion drugs online and mandates that providers explain the process, expected experiences, physical/emotional/spiritual risks, and potential reversal options to patients. The bill directly affects individuals seeking medication abortions and the health care professionals who provide them. These provisions aim to standardize access and information for medication abortions under Maine law.
LD 887 requires health care providers to be physically present during chemical abortions, including examining the patient, scheduling a follow-up within 7 days, and providing a labeled catch kit and medical waste bag for proper disposal. It makes manufacturers of abortion drugs liable for the proper disposal of the drugs and cleanup if endocrine disruptors (chemicals interfering with hormones) are found in wastewater, imposing $20,000 civil penalties for violations. The bill directly affects providers prescribing abortion drugs, manufacturers of these drugs, and patients receiving chemical abortions. Exceptions apply only for life-threatening medical emergencies. This bill does not change the legal status of abortion but adds specific procedural and disposal requirements.
